Indian Pharma Network
For Urgent Support
24/7 Free Support
Call US
+91 9891296838 / 9811747774
BOSULIF (bosutinib) tablets, for oral use.
Available in India.
BOSULIF (bosutinib) tablets is used for the treatment of patients with chronic myelogenous leukemia (CML). Brand Bosutinib tablets can be imported for personal use under "patient name basis" treatment in India. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import. If you have questions, please email IPN Support Team or Call Indian Pharma Network on +91 9891296838 (Mr. Tarun) / 9811747774 (Mr. Neeraj) for price list or cost in India.
BOSULIF (bosutinib) tablets is used for the treatment of patients with chronic myelogenous leukemia (CML)
BOSULIF is a prescription medicine used to treat adults who have a certain type of leukemia called Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) who are newly diagnosed or who no longer benefit from or did not tolerate other treatment.
BOSULIF (bosutinib) tablets suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, India. with over 20 years of domain experience.
For procurement cost of BOSULIF (bosutinib) tablets brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the BOSULIF (bosutinib) tablets tablets cost price in India.
The order for BOSULIF (bosutinib) tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Bosutinib (codenamed SKI-606, marketed under the trade name Bosulif) is a small molecule BCR-ABL and src tyrosine kinase inhibitor used for the treatment of chronic myelogenous leukemia.
BOSULIF (bosutinib) tablets tablets, for oral use.
Generic Name: bosutinib
Tablets: 100 mg and 500 mg. (
Get In Touch
Indian Pharma Network
60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016
Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398
Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in
BOSULIF (bosutinib) tablets suppliers in India
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand BOSULIF (bosutinib) tablets on prescription and Import License in Patient's Name only.
For overseas patients, BOSULIF (bosutinib) tablets can be made available in Send your enquiry to find BOSULIF (bosutinib) tablets in U.S., Canada, Mexico, Europe, Germany, France, UK, Italy, Spain, Japan, China, Australia, New Zealand, India, South Korea, Mexico, Argentina, Bolivia, Brazil, Chile, Colombia, Peru, Turkey, Costa Rica, Cuba, Saudi Arabia, South Africa, Ukraine, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
News / Update for Alunbrig (bosutinib).
For BOSULIF (bosutinib) tablets Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
FDA Approves Bosutinib (Bosulif) for Chronic Myeloid Leukemia (CML) For More Details
U.S. FDA APPROVES PFIZER’S BOSULIF® (BOSUTINIB) FOR THE TREATMENT OF PATIENTS WITH NEWLY-DIAGNOSED PH+ CHRONIC MYELOGENOUS LEUKEMIA (CML) For More Details
Get Access To BOSULIF (bosutinib) tablets In India
Indian Pharma Network (IPN), Delhi India is a leading Pharmaceutical Distributor / Supplier / Exporter / Importer of Anti-Cancer Medicines, used in chronic myeloid leukemia (CML) treatment. Brand Name "BOSULIF (bosutinib) tablets" or Generic Name "bosutinib tablets" can be imported for personal use under "patient name basis" treatment in Delhi, Noida, Gurgaon, Mumbai, Chennai, Kolkatta, Bangalore, Jaipur, Chandigarh India. Contact us at urgent@indianpharmanetwork.co.in or call/WhatsApp at +91 9891296838 / 9811747774 to get access as per norms.
